Näytä suppeat kuvailutiedot

dc.contributor.authorNémeth, János
dc.contributor.authorTapasztó, Beáta
dc.contributor.authorAclimandos, Wagih A
dc.contributor.authorKestelyn, Philippe
dc.contributor.authorJonas, Jost B
dc.contributor.authorDe Faber, Jan-Tjeerd H N
dc.contributor.authorJanuleviciene, Ingrida
dc.contributor.authorGrzybowski, Andrzej
dc.contributor.authorNagy, Zoltán Zsolt
dc.contributor.authorPärssinen, Olavi
dc.contributor.authorGuggenheim, Jeremy A
dc.contributor.authorAllen, Peter M
dc.contributor.authorBaraas, Rigmor C
dc.contributor.authorSaunders, Kathryn J
dc.contributor.authorFlitcroft, Daniel Ian
dc.contributor.authorGray, Lyle S
dc.contributor.authorPolling, Jan Roelof
dc.contributor.authorHaarman, Annechien EG
dc.contributor.authorTideman, J Willem L
dc.contributor.authorWolffsohn, James Stuart
dc.contributor.authorWahl, Siegfried
dc.contributor.authorMulder, Jeroen A
dc.contributor.authorSmirnova, Irina Yurievna
dc.contributor.authorFormenti, Marino
dc.contributor.authorRadhakrishnan, Hema
dc.contributor.authorResnikoff, Serge
dc.date.accessioned2021-03-15T12:21:03Z
dc.date.available2021-03-15T12:21:03Z
dc.date.issued2021
dc.identifier.citationNémeth, J., Tapasztó, B., Aclimandos, W. A., Kestelyn, P., Jonas, J. B., De Faber, J.-T. H. N., Januleviciene, I., Grzybowski, A., Nagy, Z. Z., Pärssinen, O., Guggenheim, J. A., Allen, P. M., Baraas, R. C., Saunders, K. J., Flitcroft, D. I., Gray, L. S., Polling, J. R., Haarman, A. E., Tideman, J. W. L., . . . Resnikoff, S. (2021). Update and guidance on management of myopia : European Society of Ophthalmology in cooperation with International Myopia Institute. <i>European Journal of Ophthalmology</i>, <i>31</i>(3), 853-883. <a href="https://doi.org/10.1177/1120672121998960" target="_blank">https://doi.org/10.1177/1120672121998960</a>
dc.identifier.otherCONVID_51890888
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/74633
dc.description.abstractThe prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesEuropean Journal of Ophthalmology
dc.rightsCC BY-NC 4.0
dc.subject.othermyopia
dc.subject.otherpathologic myopia
dc.subject.otherpreventive medicine
dc.subject.otherblindness
dc.subject.othertime spent outdoors
dc.subject.othermyopia reduction interventions
dc.subject.otheratropine
dc.subject.otherorthokeratology
dc.titleUpdate and guidance on management of myopia : European Society of Ophthalmology in cooperation with International Myopia Institute
dc.typereview article
dc.identifier.urnURN:NBN:fi:jyu-202103151974
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bc
dc.description.reviewstatuspeerReviewed
dc.format.pagerange853-883
dc.relation.issn1120-6721
dc.relation.numberinseries3
dc.relation.volume31
dc.type.versionpublishedVersion
dc.rights.copyright© The Author(s) 2021
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysosokeus
dc.subject.ysonäkövammat
dc.subject.ysosilmätaudit
dc.subject.ysolikinäköisyys
dc.subject.ysoehkäisevä lääketiede
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p77
jyx.subject.urihttp://www.yso.fi/onto/yso/p1450
jyx.subject.urihttp://www.yso.fi/onto/yso/p12047
jyx.subject.urihttp://www.yso.fi/onto/yso/p5995
jyx.subject.urihttp://www.yso.fi/onto/yso/p17163
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.1177/1120672121998960
jyx.fundinginformationAG is funded by Institute for Research in Ophthalmology (Number: Unrestricted Grant 1/2020). JAG is funded by Welsh Government and Fight for Sight (Number: 24WG201). The author(s) disclosed receipt of the following financial support for the online publication of this article: The open access fee for this publication is paid by the International Myopia Institute (IMI).
dc.type.okmA2


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC 4.0